Emily Shava

Emily Shava

Botswana-Harvard AIDS Institute Partnership - Gaborone / Botswana
Others
AD Scientific Index ID: 4994901
Botswana–Harvard AIDS Institute Partnership
person_outline Emily Shava's MOST POPULAR ARTICLES
1-) Antiretroviral therapy for the prevention of HIV-1 transmission New England Journal of Medicine 375 (9), 830-839, 2016
2-) Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial The Lancet 399 (10337), 1779-1789, 2022
3-) Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition New England Journal of Medicine 384 (11), 1003-1014, 2021
4-) A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa … JAIDS Journal of Acquired Immune Deficiency Syndromes 87 (1), 680-687, 2021
5-) A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa … JAIDS Journal of Acquired Immune Deficiency Syndromes 87 (1), 680-687, 2021